Literature DB >> 23443341

When the tumour is not the culprit: avascular necrosis of the hip in a patient with castration-resistant prostate cancer.

E Chan1, G Chan, L Ehrlich, P Hull, H Kreder, W Chu, E Chow, U Emmenegger.   

Abstract

Avascular necrosis (avn) of the hip is a well-documented side effect of corticosteroid therapy, but it has also been described as a complication of radiation and chemotherapy. Many prostate cancer patients undergo treatment with all three of those therapeutic modalities, and yet reported cases of avn of the hip in prostate cancer patients are rare. Symptoms that might potentially alert physicians to this complication are nonspecific and may be attributed to cancer progression, in particular to progressive bone metastasis.Here, we report on a 79-year-old man diagnosed with castration-resistant prostate cancer whose diagnosis of avn of the hip was confounded by his underlying malignancy. We discuss risk factors and diagnostic clues in this differential diagnosis of acute hip pain in patients with castration-resistant prostate cancer. Physicians might maintain a high index of suspicion for avn of the hip in prostate cancer patients presenting with new-onset hip pain. Surgical intervention may help to prevent the appearance of avn-associated pain and the negative impact of advanced avn on overall quality of life.

Entities:  

Keywords:  Castration-resistant prostate cancer; avascular necrosis; bisphosphonate; chemotherapy; corticosteroid; radiotherapy

Year:  2013        PMID: 23443341      PMCID: PMC3557343          DOI: 10.3747/co.20.1206

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  11 in total

Review 1.  Osteonecrosis of the femoral head: etiology, imaging and treatment.

Authors:  Konstantinos N Malizos; Apostolos H Karantanas; Sokratis E Varitimidis; Zoe H Dailiana; Konstantinos Bargiotas; Thomas Maris
Journal:  Eur J Radiol       Date:  2007-06-06       Impact factor: 3.528

2.  Zoledronic acid induced osteonecrosis of tibia and femur.

Authors:  S Gupta; P Jain; P Kumar; P M Parikh
Journal:  Indian J Cancer       Date:  2009 Jul-Sep       Impact factor: 1.224

3.  Osteonecrosis of the acetabulum following radiation therapy. A report of two cases.

Authors:  H W Deleeuw; L A Pottenger
Journal:  J Bone Joint Surg Am       Date:  1988-02       Impact factor: 5.284

Review 4.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 5.  Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Authors:  Douglas E Peterson; Wolfgang Doerr; Allan Hovan; Andres Pinto; Debbie Saunders; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-06       Impact factor: 3.603

6.  Avascular necrosis of the femoral head in patients with prostate cancer treated with cyproterone acetate and radiotherapy.

Authors:  A G Macdonald; J D Bissett
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

7.  Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

Authors:  Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawrence Karsh; Piotr Milecki; Neal Shore; Michael Rader; Huei Wang; Qi Jiang; Sylvia Tadros; Roger Dansey; Carsten Goessl
Journal:  Lancet       Date:  2011-02-25       Impact factor: 79.321

Review 8.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

9.  Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head.

Authors:  Wakaba Fukushima; Mikihiro Fujioka; Toshikazu Kubo; Akiko Tamakoshi; Masaki Nagai; Yoshio Hirota
Journal:  Clin Orthop Relat Res       Date:  2010-03-12       Impact factor: 4.176

Review 10.  The use of bisphosphonate in the treatment of avascular necrosis: a systematic review.

Authors:  Juliana Bahia Cardozo; Débora Motta S Andrade; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2008-02-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.